Recombinant Factor IX

Factor IX · CSL Behring

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Factor IX, covering 2016-05-09 to 2016-05-09. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of a Recombinant Factor IX in Patients With Severe Hemophilia B [Phase 1, Phase 2]